Avanti il prossimo

Riproduzione automatica

Anastrozole offers higher breast cancer-free survival rates than tamoxifen following DCIS

1 Visualizzazioni • 07/16/23
Condividere
Incorporare
administrator
administrator
Iscritti
0

Visit http://www.ecancer.org for more

Prof Margolese (The Jewish General Hospital, McGill University, Montreal, Canada) talks to ecancertv at ASCO 2015 about a federally funded phase III trial that suggests postmenopausal women with ductal carcinoma in situ (DCIS) may have an additional option for breast cancer prevention.

Mostra di più
0 Commenti sort Ordina per
Commenti su Facebook

Avanti il prossimo

Riproduzione automatica